Ranbaxy gets tentative U.S. nod for dementia drug
MUMBAI, Dec 28 (Reuters) - Indian drug maker Ranbaxy Laboratories Ltd (RANB.BO: Quote, Profile, Research, Stock Buzz) has received tentative approval from the U.S. Food and Drug Administration for galantamine hydrobromide oral solution, the regulator's Web site showed.
The drug, a generic version of Razadyne, is indicated in the treatment of mild to moderate dementia. (Reporting by Rina Chandran; Editing by John Mair)
© Thomson Reuters 2008 All rights reserved
Ads by Career Builder
Director of Case Management -Healthcare -Wisconsin
Details: ...Case Management -Healthcare -Hospital Director of Case Management -Healthcare -Wisconsin Are...Case Management -Healthcare -Wisconsin position...
Medical & Healthcare Opportunities
Details: ...in life. Medical / Healthcare Some of the opportunities...in the Medical and Healthcare area include: Dental...
Work from Home as a Healthcare Recruiter
Details: ...from Home as a Healthcare Recruiter Health...an international healthcare recruiting and...represents high-demand healthcare professionals and...
Executive Recruiter - Healthcare
Details: ...about starting a career in healthcare recruiting, please respond...Staffing, Recruitment, Nurse, Healthcare, Health Care, Health Care...
Entertainment
Tropical storm Hanna drenches U.S.
